Post job

AlixaRx CEO and executives

Executive Summary. Based on our data team's research, Brad Savage is the AlixaRx's CEO. AlixaRx has 250 employees, of which 2 are in a leadership position.
Work at AlixaRx?
Share your experience

Rate AlixaRx's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Brad Savage

Chief Executive Officer

Brad Savage's LinkedIn

Mr. Savage was a founding executive and now serves as Chief Executive Officer of AlixaRx, an innovative pharmacy company leveraging technology to redefine post-acute pharmacy services. With almost 30 years of experience, Mr. Savage is a seasoned executive with experience in product development, technology, and operations with private equity backed healthcare organizations and Fortune 50 companies. Prior to joining AlixaRx, he served for five years as Chief Information Officer of Golden Living, one of the nation’s largest post-acute care providers. He has also served in leadership roles in technology companies including Apple Computer, Netscape Communications, America Online, and healthcare technology consulting with Lionbridge Technologies.Specialties: Pharmacy, Pharmacy Automation, Post-Acute, Long Term Care, Strategy, Health Information Technology, Business Development, Application Development, Operations, Staff Development

Ronald Silva

Board Member

Do you work at AlixaRx?

Does the leadership team provide a clear direction for AlixaRx?

AlixaRx jobs

AlixaRx board members

Name & TitleBio
Ronald Silva

Board Member

AlixaRx executives FAQs

Zippia gives an in-depth look into the details of AlixaRx, including salaries, political affiliations, employee data, and more, in order to inform job seekers about AlixaRx. The employee data is based on information from people who have self-reported their past or current employments at AlixaRx. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by AlixaRx. The data presented on this page does not represent the view of AlixaRx and its employees or that of Zippia.

AlixaRx may also be known as or be related to AlixaRx and Alixarx.